Page last updated: 2024-10-21

2-aminoethoxydiphenyl borate and Scleroderma, Systemic

2-aminoethoxydiphenyl borate has been researched along with Scleroderma, Systemic in 2 studies

2-aminoethoxydiphenyl borate: is a novel membrane-penetrable modulator and transient receptor potential channel blocker; structure in first source; do not confuse with 2-APB cpd
2-aminoethoxydiphenylborane : An organoboron compound that is diphenylborane in which the borane hydrogen is replaced by a 2-aminoethoxy group.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hsu, WL2
Hsieh, YC1
Yu, HS2
Yoshioka, T2
Wu, CY2
Tsai, MH1
Chai, CY1
Yen, CJ1
Chen, CH1
Lu, JH1

Other Studies

2 other studies available for 2-aminoethoxydiphenyl borate and Scleroderma, Systemic

ArticleYear
2-Aminoethyl diphenylborinate inhibits bleomycin-induced skin and pulmonary fibrosis via interrupting intracellular Ca
    Journal of dermatological science, 2021, Volume: 103, Issue:2

    Topics: Adult; Aged; Animals; Bleomycin; Boron Compounds; Calcium Signaling; Case-Control Studies; Cell Dedi

2021
A potential new approach for treating systemic sclerosis: Dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca2+ entry.
    PloS one, 2019, Volume: 14, Issue:3

    Topics: Boron Compounds; Calcium Channel Blockers; Calcium Signaling; Cell Dedifferentiation; Cells, Culture

2019